Clinical Trial Update: A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial compares two schedules of ixabepilone plus bevacizumab with paclitaxel plus bevacizumab in metastatic breast cancer, and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Ixabepilone (ixabepilone)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: R-Pharm | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-04-14